Paola De Giorgio

Structure−Affinity Relationship Study on <i>N</i>-[4-(4-Arylpiperazin-1-yl)butyl]arylcarboxamides as Potent and Selective Dopamine D₃ Receptor Ligands

Marcello Leopoldo, Francesco Berardi, Nicola Antonio Colabufo et al. · Journal of Medicinal Chemistry · 2002 · 74 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Structural Modifications of <i>N</i>-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-Aryl-1-piperazinehexanamides: Influence on Lipophilicity and 5-HT₇ Receptor Activity. Part III

Marcello Leopoldo, Enza Lacivita, Paola De Giorgio et al. · Journal of Medicinal Chemistry · 2008 · 69 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Determination of 1-aryl-4-propylpiperazine pKa values: The substituent on aryl modulates basicity

Enza Lacivita, Marcello Leopoldo, Paola De Giorgio et al. · Bioorganic & Medicinal Chemistry · 2008 · 48 citations

Pharmacy, Chemistry, Medicinal Chemistry +11

Investigations on the 1-(2-Biphenyl)piperazine Motif: Identification of New Potent and Selective Ligands for the Serotonin₇ (5-HT₇) Receptor with Agonist or Antagonist Action in Vitro or ex Vivo

Enza Lacivita, Daniela Patarnello, Nikolas Stroth et al. · Journal of Medicinal Chemistry · 2012 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Synthesis, radiolabeling and in vivo evaluation of [11C](R)-1-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT7 receptor

Hanne D. Hansen, Enza Lacivita, Pantaleo Di Pilato et al. · European Journal of Medicinal Chemistry · 2014 · 32 citations

Medicine, Nuclear Medicine, Pharmacology +16